Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.96 USD | -0.13% | -4.47% | -21.06% |
Chart calendar Zentalis Pharmaceuticals, Inc.
Upcoming events on Zentalis Pharmaceuticals, Inc.
Past events on Zentalis Pharmaceuticals, Inc.
2024-05-07 07:00 am | Q1 2024 Earnings Release |
2024-04-09 04:30 pm | American Association for Cancer Research Meeting - Abstract Number: 6487 |
2024-03-11 | Jefferies Biotech on the Bay Summit |
2024-03-11 03:20 pm | Leerink Partners Global Biopharma Conference |
2024-03-05 10:30 am | TD Cowen Health Care Conference |
2024-02-27 07:00 am | Q4 2023 Earnings Release |
2024-02-14 12:40 pm | Oppenheimer Healthcare Life Sciences Conference - Fireside Chat |
2023-11-15 03:30 am | Jefferies London Healthcare Conference |
2023-11-10 10:00 am | Investor Meeting - Key Opinion Leader |
2023-11-06 07:18 am | Q3 2023 Earnings Release |
2023-09-13 10:10 am | Morgan Stanley Global Healthcare Conference |
2023-08-09 07:00 am | Q2 2023 Earnings Release |
2023-06-16 09:30 am | Annual General Meeting |
2023-06-06 08:00 am | American Society of Clinical Oncology Meeting |
2023-06-05 05:30 pm | American Society of Clinical Oncology Conference - Abstract Number:5513 |
2023-06-05 02:15 pm | American Society of Clinical Oncology Conference |
2023-05-10 07:00 am | Q1 2023 Earnings Release |
2023-04-17 01:30 pm | American Association for Cancer Research Meeting - Abstract No: 2796 |
2023-04-17 09:00 am | American Association for Cancer Research Meeting - Abstract No - 2153 |
2023-03-01 07:00 am | Q4 2022 Earnings Release |
Annual results
Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 29,1 |
EBITDA Million USD | Released Forecast Spread | 0,00 | -119 -118 -0.2% | -216 -235 7.97% | -226 -230 1.98% | -298 -269 -10.63% | -233 |
EBIT Million USD | Released Forecast Spread | 0,00 | -119 -116 -2.36% | -217 -233 7.22% | -227 -236 3.81% | -300 -291 -3.02% | -241 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -118 -115 -2.65% | -165 -167 1.21% | -221 -238 7.06% | -277 -280 0.99% | -192 |
Net income Million USD | Released Forecast Spread | -46,4 | -119 -114 -3.68% | -159 -174 8.59% | -237 -239 0.92% | -292 -291 -0.43% | -199 |
EPS USD | Released Forecast Spread | -8,16 | -4,19 -4,88 14.1% | -3,72 -4,01 7.34% | -4,48 -4,58 2.15% | -4,47 -4,53 1.43% | -2,81 |
Announcement Date | 06/03/20 | 25/03/21 | 24/02/22 | 01/03/23 | 27/02/24 | - |
Quarterly results
Fiscal Period | December | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 40,6 11,7 247.66% | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
EBITDA Million USD | Released Forecast Spread | -51,4 -55,0 6.51% | |||||||||||||
EBIT Million USD | Released Forecast Spread | -57,9 -55,0 -5.22% | -63,5 -58,2 -9.11% | -54,2 -63,0 13.91% | -51,8 -61,6 15.98% | -65,0 -56,2 -15.66% | -104 -63,2 -64.44% | -62,7 -62,3 -0.75% | -67,9 -64,0 -6.13% | -24,8 -55,6 55.46% | -67,7 | -69,6 | -78,2 | -71,6 | -73,5 |
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -57,5 -55,4 -3.8% | -63,0 -55,5 -13.49% | -52,3 -60,8 14% | -48,5 -63,5 23.59% | -60,8 -56,5 -7.74% | -99,5 -62,5 -59.04% | -55,5 -59,9 7.32% | -61,1 -59,2 -3.17% | 10,2 -53,1 119.17% | -58,1 | -60,8 | -78,5 | -69,8 | -71,5 |
Net income Million USD | Released Forecast Spread | -59,1 -54,4 -8.59% | -68,4 -57,0 -19.91% | -54,4 -62,1 12.46% | -55,0 -61,9 11.18% | -63,2 -55,9 -13.19% | -113 -63,0 -78.62% | -55,5 -63,8 12.9% | -60,9 -61,5 0.96% | 10,1 -56,7 117.76% | -60,7 | -63,8 | -82,0 | -71,2 | -73,7 |
EPS USD | Released Forecast Spread | -1,31 -1,21 -8.66% | -1,34 -1,19 -12.2% | -0,96 -1,21 20.55% | -0,92 -1,06 13.39% | -1,07 -1,02 -4.9% | -1,85 -1,04 -78.16% | -0,79 -0,94 16.32% | -0,83 -0,90 7.49% | 0,14 -0,75 118.74% | -0,85 | -0,89 | -1,06 | -0,92 | -0,95 |
Announcement Date | 05/05/22 | 09/08/22 | 09/11/22 | 01/03/23 | 10/05/23 | 09/08/23 | 06/11/23 | 27/02/24 | 07/05/24 | - | - | - | - | - |
Past sector events for Zentalis Pharmaceuticals, Inc.
Today 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
2024-05-16 07:46 am | BIOCON LIMITED: Q4 2024 Earnings Release |
2024-05-16 01:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
2024-05-15 08:05 am | THIRD HARMONIC BIO, INC.: Q1 2024 Earnings Release |
2024-05-15 07:00 am | CABALETTA BIO, INC.: Q1 2024 Earnings Release |
2024-05-14 | TAIMED BIOLOGICS INC.: Q1 2024 Earnings Release |
2024-05-15 04:01 pm | CELCUITY INC.: Q1 2024 Earnings Release |
2024-05-14 04:05 pm | ENLIVEN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 04:00 pm | ARCUTIS BIOTHERAPEUTICS, INC.: Q1 2024 Earnings Release |
2024-05-14 08:00 am | IMMUNOME, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ZNTL Stock
- Calendar Zentalis Pharmaceuticals, Inc.